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Introduction
The filamentous fungus Aspergillus terreus is primarily 
associated with the biotechnological production of two 
valuable metabolites, namely itaconic acid and lovastatin. 
The former has a wide range of applications in polymer 
manufacturing (Robert and Friebel 2016; Willke and Vor-
lop 2001), while the latter is used as a cholesterol-lowering 
drug and a starting material for the production of semisyn-
thetic statins in the pharmaceutical industry (Tobert 2003). 
These two molecules are the textbook examples of industri-
ally relevant fungal metabolites.
The production of itaconic acid and lovastatin is 
encoded within the genomic segments referred to as the 
biosynthetic gene clusters (Brakhage 2013; Keller 2015). 
The clusters can be described as the groups of neighboring 
genes collectively responsible for the biosynthesis of a par-
ticular metabolite. Following the sequencing of A. terreus 
NIH 2624 genome at the BROAD Institute, the bioinfor-
matic analyses revealed the presence of more than 10,000 
putative protein-encoding sequences. Remarkably, it was 
later observed that the gene clusters corresponding to lov-
astatin and itaconic acid biosynthesis are situated next to 
one another in the genome of A. terreus (Li et al. 2011). In 
other words, the two metabolites responsible for the “bio-
tech career” of A. terreus were found to be encoded within 
a relatively small segment of DNA comprised of several 
genes.
The hierarchical level of genetic organization was 
discovered to exist in fungal genomes in the form of the 
so-called superclusters (Wiemann et  al. 2013), which 
can be understood as biosynthetic gene clusters grouped 
within larger genomic units (“clusters of clusters”). In 
the light of these findings, it is tempting to speculate 
that the lovastatin and itaconic acid clusters, which are 
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situated adjacent to one another, may be the members of 
a coordinately regulated supercluster of great biotechno-
logical importance, shaped and optimized in the course 
of evolution. However, there is currently no experimen-
tal evidence that the two clusters may share a common 
regulatory mechanism or that their production is jointly 
coordinated at a molecular level. Despite the adjacent 
positions of the two biosynthetic gene clusters, the likeli-
hood of the existence of common regulation is rather low. 
In fact, there is only one literature record regarding the 
parallel biosynthesis of lovastatin and itaconic acid by 
an individual strain, namely A. terreus ATCC 20542 (Lai 
et  al. 2007). The authors noted that lovastatin produc-
tion was enhanced when itaconic acid at the concentra-
tion of 0.5 g  l− 1 was supplemented to the medium. It was 
thus suggested that there might have been a relationship 
between the biosynthesis of these two molecules. To the 
best of our knowledge, the biosynthetic co-occurrence of 
itaconic acid and lovastatin was never reported in sub-
sequent studies. It is likely that the strains isolated for 
the purpose of lovastatin manufacturing are very poor 
producers of itaconic acid and vice versa. In the afore-
mentioned study of Lai et al. (2007) the strain A. terreus 
ATCC 20542, a basic lovastatin-producing strain, pro-
duced only about 0.5 g  l− 1 of itaconic acid. This is a very 
small concentration if compared to the titers exceeding 
130 g  l− 1 obtained with the use of A. terreus NRRL 1960 
(Karaffa et al. 2015) or A. terreus DSM 23081 (Hevekerl 
et al. 2014b).
In the absence of detailed molecular characterization 
of the underlying regulatory pathways, the comparative 
discussion on the production of lovastatin and itaconic 
acid can be attempted on the basis of bioprocess-related 
observations originating from industrial and academic 
optimization studies. Thus, the aim of this mini-review 
is to outline the similarities and differences with respect 
to the conditions favoring the production of lovasta-
tin and itaconic acid by A. terreus. For the purpose of 
comparison, only the selected aspects of biosynthesis 
are discussed here, however the readers may consult the 
previous reviews on the production of lovastatin (Bar-
rios-Gonzalez and Miranda 2010; Bizukojc and Leda-
kowicz 2015; Manzoni and Rollini 2002; Mulder et  al. 
2015; Subhan et  al. 2016) and itaconic acid (Klement 
and Buchs 2013; Okabe et  al. 2009; Steiger et  al. 2013; 
Willke and Vorlop 2001) for further insights. While the 
influence of the respective parameters on the productiv-
ity of the process is always strain-specific and depends on 
the applied cultivation strategy, certain generalizations 
can still be made to open the door for the comparative 
discussion on lovastatin and itaconic acid production. 
The formulation of such general remarks is attempted in 
the current review.
Biosynthesis
The molecules of lovastatin and itaconic acid are markedly 
different with respect to chemical structure and originate 
from secondary and primary metabolism, respectively. The 
biochemistry of itaconic acid production was the subject of 
the previous review (Steiger et al. 2013). Itaconic acid is an 
unsaturated dicarboxylic acid, which is formed via decar-
boxylation of cis-aconitic acid in the reaction catalyzed by 
cis-aconitate decarboxylase (CadA) (Bonnarme et al. 1995; 
Jaklitsch et al. 1991; Kanamasa et al. 2008; Li et al. 2011; 
Winskill 1983). Other proteins important for the biosyn-
thesis of itaconic acid are the mitochondrial cis-aconitic 
acid transporter (MttA) and a putative major facilitator 
superfamily transporter. Importantly, a pathway involves 
the MttA-mediated transport of cis-aconitic acid from the 
mitochondrion to the cytosol, where the decarboxylation 
leading to itaconic acid occurs (Steiger et al. 2016). Li et al. 
(2011, 2013) employed a transcriptomic approach to iden-
tify the genes associated with itaconic acid production. In 
addition to the itaconic acid gene cluster itself, the authors 
reported a number of genes involved in glycolysis, pentose 
phosphate pathway, production of vitamins and copper 
transport.
The biosynthetic route leading to lovastatin is much 
more complex. It is based on the action of two multi-
domain polyketide synthases (PKS), namely the lovastatin 
nonaketide synthase (LovB) and the lovastatin diketide syn-
thase (LovF), responsible for assembling the carbon skel-
eton of lovastatin using the acetyl-CoA and malonyl-CoA 
units. Additionally, a number of other enzymes participate 
in the so-called post-PKS tailoring steps leading to the final 
structure of lovastatin. The pathway proceeds through a 
number of intermediates, including 4a,5-dihydromonaco-
lin L, 3α-hydroxy-3,5-dihydromonacolin L, monacolin L 
and monacolin J (Alberts et al. 1980; Barriuso et al. 2011; 
Cacho et al. 2015; Kennedy et al. 1999; Xu et al. 2013).
The difference in complexity between the metabolic 
pathways leading to lovastatin and itaconic acid is illus-
trated in Fig.  1. For comparison, the molecule of acetyl-
CoA is depicted as the starting point of both pathways in 
order to demonstrate the relationship of the presented bio-
synthetic routes to the respective core metabolic precursors.
Acetyl-CoA is one of the key precursors situated at the 
intersection of many metabolic pathways. It fuels the car-
bon building blocks for the biosynthesis of fatty acids and 
the intermediates of the citric acid cycle. It is also involved 
in the regulation of metabolic activity within the cell. 
Importantly, it provides a link between primary and sec-
ondary metabolism by delivering the carbon skeleton for 
diverse groups of secondary metabolites, e.g. polyketides 
and terpenes (Chiang et al. 2010; Shi and Tu 2015). How-
ever, the regulation of its distribution between primary and 
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secondary pathways remains to be elucidated, primarily 
due to the complexity of the regulatory machinery involved 
in secondary metabolism, which is far from being fully 
understood (Brakhage 2013).
As already mentioned in the introduction, due to the 
adjacency of itaconic acid and lovastatin gene clusters, 
one may speculate about the possibility of common regu-
lation of biosynthesis of these two metabolites. Impor-
tantly, itaconic acid and lovastatin are related to different 
branches of metabolic machinery, namely to primary and 
secondary metabolism, respectively. In contrast, the fun-
gal biosynthetic gene supercluster described in literature 
(Wiemann et al. 2013) encompasses the genes associated 
with the formation of secondary metabolites. To the best 
of our knowledge, the fungal supercluster involving the 
genes of primary and secondary metabolism has never 
been reported and, accordingly, the common regulation 
of itaconic acid and lovastatin production appears rather 
unlikely despite the adjacency of respective genomic 
segments.
The maximal reported titers of itaconic acid are at the 
level of 140 g  l− 1. Accordingly, itaconic acid is considered 
a commodity chemical. In contrast, the typically reached 
lovastatin concentration values are below 1  g  l− 1 and the 
metabolite itself represents the group of high-value fine 
chemicals. The titers of lovastatin and itaconic acid are of 
different magnitudes. This fact makes the common regula-
tion of their biosynthesis even less likely.
Fig. 1  Pathways of itaconic acid (a) and lovastatin (b) biosynthesis 
in Aspergillus terreus (Ames et al. 2012; Bentley and Thiessen 1957; 
Kennedy et al. 1999; Steiger et al. 2013). The enzymes participating 
in the respective steps are indicated. The catalytic domains of lovasta-
tin nonaketide synthase LovB are shown in brackets. ACP acyl carrier 
protein; AT acyltransferase; CadA cis-aconitic acid decarboxylase; 
DH dehydratase; KS β-ketoacyl synthase; KR ketoreductase; LovA 
cytochrome P450 monooxygenase; LovB lovastatin nonaketide syn-
thase; LovC enoyl reductase; LovD acyl transferase; LovF lovastatin 
diketide synthase; mal-CoA malonyl-CoA; MT methyltransferase
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The biosynthesis of lovastatin is controlled within the 
regulatory framework of secondary metabolism (Mulder 
et  al. 2015). Regulation of fungal secondary metabolism 
involves a number of global and cluster-specific regulators, 
e.g. a global regulator LaeA and Zn(II)2Cys6 transcription 
factors, participating in the complex regulatory and sign-
aling pathways and responding to diverse environmental 
stimuli (Knox and Keller 2015). Bok and Keller (2004) 
proved that LaeA is a global regulator involved in the 
expression of lovastatin biosynthetic genes. Furthermore, 
one of the proteins encoded in the lovastatin biosynthetic 
gene cluster, namely LovE, has a zinc finger domain typi-
cally found in Zn(II)2Cys6 regulators (Kennedy et al. 1999). 
Importantly, it was shown that the onset of lovastatin pro-
duction coincides with the increase of reactive oxygen spe-
cies (ROS) and down-regulation of sod1 (a gene encoding 
the oxidative stress defense enzyme) observed during the 
idiophase (Miranda et  al. 2013). This study also demon-
strated the importance of mass transfer of oxygen in the 
cultivation broth and within the mycelia to promote the oxi-
dative state associated with lovastatin biosynthesis. It was 
then suggested that a transcription factor Yap1 could pro-
vide a link between the initiation of lovastatin production 
and the accumulation of ROS. Notably, the yap1 gene was 
highly expressed during trophophase but down-regulated 
during idiophase (Miranda et al. 2014).
In order to activate the PKS enzyme, the post-transla-
tional addition of phosphopantetheinyl group to the acyl 
carrier protein (ACP) domain of the PKS by 4′phospho-
pantetheinyl transferase (PPTase) is required (Chiang et al. 
2010). Interestingly, Márquez-Fernández et  al. (2007) 
reported that that a single PPTase is likely to be involved 
in the activation of all polyketide synthases in Aspergillus 
nidulans. Since the formation of lovastatin is dependent 
on the catalytic activity of two polyketide synthases (Hen-
drickson et al. 1999), their control is crucial for triggering 
the underlying biosynthetic pathway.
It was suggested previously that the acidification of sur-
roundings with itaconic acid may be an important survival 
strategy against competitors (Magnuson and Lasure 2004). 
Lovastatin is an inhibitor of the key step of the choles-
terol biosynthesis pathway, namely the reaction catalyzed 
by (S)-3-hydroxy-3-methylglutaryl-CoA reductase (Endo 
2010) and exhibits antifungal and antiparasitic activity 
(Keller 2015). So, both itaconic acid and lovastatin can be 
regarded as chemical means of gaining evolutionary advan-
tage in the environmental niche, albeit the mechanisms of 
providing the advantage and the scale of biosynthesis are 
markedly different for the two molecules. Supposedly, the 
relatively low levels of lovastatin secreted by A. terreus 
proved to sufficient to inhibit the proliferation of competing 
microorganisms in the natural habitat and the evolutionary 
conservation of the underlying biosynthetic pathway was 
justified in this species.
Initial pH value of growth medium
The initial pH values published in relation with itaconic 
acid production vary significantly in the range from 1.6 
(Lockwood and Moyer 1949) to 5.9 (Gyamerah 1995b). 
The experiments of Rychtera and Wase (1981) involving 
the strain A. terreus NRRL 1960 led to a conclusion that 
the initial pH value optimal for itaconic acid production is 
equal to 3.1. Following these findings, the initial pH of 3.1 
was later applied in numerous itaconic acid-related experi-
ments (Gao et al. 2014; Hevekerl et al. 2014a; Kautola et al. 
1991; Kuenz et  al. 2012). The subject was further elabo-
rated by Hevekerl et al. (2014b), who tested 6 different lev-
els of initial pH, ranging from 1.9 to 4.9, in the itaconic 
acid-oriented cultivation of A. terreus DSM 23081. Due to 
the fact that the manipulation of the initial pH value did not 
lead to any improvements in performance and seemed to be 
of secondary importance, the authors decided to conduct 
their further experiments according to the previous recom-
mendations of Rychtera and Wase (1981) at the initial pH 
of 3.1. It needs to be emphasized that in all cases examined 
by Hevekerl et al. (2014b) the onset of product biosynthe-
sis corresponded to the time when the pH decreased to the 
level of 2.1. The decrease of pH value to about 2 is a typi-
cal behavior observed at the start of itaconic acid produc-
tion (Willke and Vorlop 2001).
Despite the generally accepted approach of starting the 
lovastatin production at pH 6.5 (reviewed by Mulder et al. 
2015), it was demonstrated by Osman et  al. (2011) and 
Bizukojc et al. (2012) that applying even higher initial pH 
values of 7.5 and 8.5, respectively, can lead to the enhanced 
biosynthesis of lovastatin. On the other hand, lowering the 
initial pH value to 4.5 or 3.5 resulted in the strongly inhib-
ited biosynthesis of lovastatin by A. terreus ATCC 20542 
(Bizukojc et al. 2012). Apparently, the preferred initial pH 
value for lovastatin production is situated higher on the pH 
scale than for the formation of itaconic acid. Shifting the 
pH value in the course of the cultivation should, in prin-
ciple, allow for the production of both metabolites in the 
sequential manner. For example, an initial low pH itaconic 
acid production phase can be followed by a higher pH 
lovastatin production phase. Even though pH shifts have 
been tested during itaconic acid production, the presence 
of lovastatin in the broth have not been assayed (Hevekerl 
et  al. 2014b). The mixed cultivation approach involving 
pH shifts could provide valuable insights into the itaconic 
acid and lovastatin biosynthesis occurring in a single strain, 
provided the concentration values of both metabolites are 
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monitored throughout the cultivation process. Still, such 
approach has not been explored.
Control of pH value
Keeping the concentration of hydrogen ions within a 
certain range or at a fixed value during the cultivation is 
regarded by some authors to be an effective approach to 
increase titer, productivity and yield of itaconic acid. Sev-
eral optimization strategies involving the control of acidity 
in A. terreus cultures were proposed. As an alternative to 
continuous pH control, the individual adjustment of pH in 
the chosen time point of the run can be performed to influ-
ence the outcome of the process.
The examples of early descriptions and suggestions 
regarding pH control can be found in literature dating back 
to 1940s. Lockwood and Moyer (1949) recommended to 
maintain pH value within the range between 1.4 and 2.4 in 
order to avoid itaconic acid decomposition during the cul-
tivation. A slightly different method was applied by Nel-
son et  al. (1952), who kept pH value within the narrower 
range between 1.8 and 2.0. Later, Nubel and Ratajak (1962) 
described an approach involving partial neutralization of 
the broth with lime up to pH 3.8, which was conducted 
when the content of itaconic acid reached the level from 20 
to 50 g  l− 1. The final product was described as substantially 
free of other organic acids (Nubel and Ratajak 1962). To 
eliminate the formation of by-products, namely succinic 
acid and itatartaric acid, Batti (1964) recommended to keep 
pH value between 3 and 5 after the itaconic acid concentra-
tion in the broth reached about 50 g  l− 1.
In the aforementioned studies (Lockwood and Moyer 
1949; Nelson et  al. 1952; Nubel and Ratajak 1962; Batti 
1964) the importance of controlling pH levels during ita-
conic acid production was clearly highlighted, however the 
formulated recommendations differed significantly among 
the authors. The need for detailed experimental studies 
directly addressing the aspects of pH control was evident. 
Riscaldati et al. (2000) tested a number of diverse cultiva-
tion conditions involving pH control and, in the light of the 
gathered data, suggested to keep pH value at 2.8 in order 
to maximize itaconic acid production by A. terreus NRRL 
1960. Importantly, the authors also demonstrated the sig-
nificance of stirring speed in this context, as the final prod-
uct concentration at the controlled pH of 2.8 varied from 
17.7 g l− 1 at 320 rpm to 43.1 g l− 1 at 400 rpm. The high-
est concentration of itaconic acid obtained in the study 
(57.2 g l− 1) was recorded at the controlled pH value of 2.4 
and stirring speed of 320 rpm, but due to a relatively low 
productivity these conditions were not regarded as optimal 
(Riscaldati et al. 2000). In a different study, Rychtera and 
Wase (1981) noted the decrease in itaconic acid production 
by A. terreus NRRL 1960 when pH value was above 3.1.
Despite the existence of several reports that indicated 
the advantages of pH control during itaconic acid produc-
tion, there are examples of successful cultivations con-
ducted without any pH modifications that led to relatively 
high product titers ranging from about 90 to 130 g  l− 1 
(Kuenz et  al. 2012; Hevekerl et  al. 2014a; Karaffa et  al. 
2015). What is more, one may encounter examples of pub-
lished data sets supporting the idea that pH control can 
negatively affect the process. For instance, in a study of Li 
et al. (2011) the cultivation of A. terreus NRRL 1960 with-
out pH control resulted in the final itaconic acid concen-
tration about 3.5 times higher than that in the correspond-
ing process performed with the same initial pH but with its 
continuous control at 3.5. Recently, Hevekerl et al. (2014b) 
observed that pH control at the level equal to 3 maintained 
from the onset of cultivation resulted in a low final prod-
uct concentration of 17  g  l− 1 and clearly had a negative 
impact on the biosynthesis of itaconic acid by A. terreus 
DSM 23081. In the same study, when pH control at the 
level equal to 3 was initiated not at the beginning of culti-
vation but after the onset of product formation, the highest 
reported itaconic acid titer of 146  g  l− 1 was reached. As 
pointed out by Hevekerl et al. (2014b), it had been previ-
ously suggested that the initial growth period at lower pH is 
required for the cells to develop the biochemical machinery 
responsible for itaconic acid biosynthesis (Larsen and Eim-
hjellen 1955).
While certain studies indicated that a poorly designed 
pH control strategy may have a negative impact on the pro-
duction of itaconic acid (Hevekerl et  al. 2014b; Li et  al. 
2011), it was also demonstrated that a well-chosen pH con-
trol scheme is a valuable approach of process optimization, 
provided that certain factors are taken into consideration. 
These factors include the careful choice of the pH value 
itself and the moment of pH control initiation (Hevekerl 
et  al. 2014b). Furthermore, other process parameters, e.g. 
stirring speed, should be monitored in concert with pH in 
order to reach satisfactory product concentration (Riscal-
dati et  al. 2000). Whereas previous experiments indicated 
that maintaining a constant value of pH is not a prerequisite 
for attaining high itaconic acid titers and its importance is 
rather debatable in this context, the adjustment of pH was 
shown to reduce the formation of by-products (Batti 1964) 
and increase the solubility of itaconic acid in the broth 
(Hevekerl et al. 2014b).
Control of pH during lovastatin production has been 
applied in several studies. Whenever the authors decided 
to maintain the control, the pH value was generally within 
the range of pH 5.8–7.8 (Bizukojc and Ledakowicz 2008; 
Kumar et al. 2000; Lai et al. 2005; Novak et al. 1997; Paw-
lak et  al. 2012; Pawlak and Bizukojc 2013). Clearly, this 
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interval does not overlap with the more acidic conditions 
close to pH value between 2 and 3, typically employed for 
establishing high-yield itaconic acid production processes.
Interestingly, the pH regime associated with maximal 
itaconic acid production do not correspond with the pH 
value optimal with respect to A. terreus biomass yield, 
which was determined by Mathan et al. (2013) to be around 
pH 5.5. It indicates that itaconic acid production is trig-
gered at the conditions suboptimal for growth. It is possi-
ble that the formation of itaconic acid serves as a metabolic 
strategy to utilize the surplus of citric acid intermediates in 
growth-limiting conditions.
Similarly as in the case of itaconic acid production, the 
significance of pH control with regard to the biosynthesis of 
lovastatin is rather controversial. Lai et al. (2005) addressed 
this subject in a series of experiments involving A. ter-
reus ATCC 20542. The control of pH value in the range 
between 5.5 and 7.5 was applied starting from the 48  h 
of the cultivation. In comparison with the run performed 
without the pH control, no improvements in terms of lovas-
tatin titers were recorded at pH level equal to 6.5, whereas 
at pH levels equal to 5.5 and 7.5 the pH control had a vis-
ibly negative impact on the process. While the study of Lai 
et al. (2005) did not provide any justification for controlling 
the level of pH during lovastatin production, this approach 
was then advocated by Bizukojc and Ledakowicz (2008), 
who described the positive impact of pH control on lovas-
tatin production by A. terreus ATCC 20542. Specifically, 
keeping the pH at the level of 7.6 or 7.8 starting from the 
24 h by using sodium and potassium carbonate allowed for 
the suppression of the production of (+)-geodin, a second-
ary metabolite often found to co-occur with lovastatin in 
the broth (Askenazi et al. 2003; Bizukojc and Ledakowicz 
2007). In the light of these findings, the reduction of by-
product formation can be viewed as the main rationale for 
applying pH control during lovastatin production.
Considering the aforementioned studies it is tempting 
to generalize that, in the words of Dowdells et al. (2010), 
“Aspergillus terreus produces itaconic acid at low pH but 
lovastatin (…) at higher pH”. Indeed, the experimental 
results obtained so far strongly indicate that the optimal 
values of pH for itaconic acid and lovastatin differ signifi-
cantly. However, as discussed in the current review, the pH 
value is merely one of the factors affecting the biosynthesis 
of these two molecules. Other cultivation parameters and, 
most importantly, the associated regulatory mechanisms 
are also of great importance in this context and should not 
be overlooked.
The production of itaconic acid is not the only fungal 
cultivation that requires low pH values. The best-studied 
example of a process proceeding at low pH values is 
the production of citric acid by Aspergillus niger. Both 
citric acid and the precursor of itaconic acid, namely 
cis-aconitic acid, originate from the citric acid cycle. 
As reviewed by Klement and Buchs (2013), itaconic 
acid production is sometimes regarded as “citric acid 
production, but in the presence of a cis-aconitate decar-
boxylase”. During the production of citric acid the pH 
value of the broth must be kept below pH 2.5 to achieve 
product accumulation (Kubicek and Karaffa 2006). 
At low pH values the formation of other organic acids, 
namely gluconic acid and oxalic acid, is suppressed and 
the risk of contamination is highly reduced (Karaffa and 
Kubicek 2003; Papagianni 2007). Similarly, the signifi-
cance of low pH with respect to preventing by-product 
formation has also been described for the production of 
itaconic acid (Batti 1964). Due to the pKa values of cit-
ric acid, equal to 3.1, 4.7 and 6.4, the accumulation of 
the certain amount of the product in the medium leads 
to the automatic decrease of pH value to 1.8, unless the 
medium is strongly buffered, e.g. in the presence of glu-
tamate (Kubicek and Karaffa 2006). The pKa values of 
itaconic acid (3.8 and 5.5) are within the range of pKa 
values exhibited by citric acid (Mondala 2015) and can 
be associated with the drop of the pH value at the onset 
of itaconic acid accumulation (Hevekerl et al. 2014b).
The dedicated enzyme of the itaconic acid biosynthesis 
pathway, cis-aconitate decarboxylase (CadA), was dem-
onstrated to exhibit maximal activity at pH 6.2. The activ-
ity declined significantly up to pH 7.5. Below pH 4.5 the 
enzyme was inactive (Dwiarti et  al. 2002). However, it 
should be noted that the enzyme is localized in the cyto-
sol (Jaklitsch et al. 1991) and is not directly exposed to low 
extracellular pH values. In contrast, glucose oxidase, par-
ticipating in the formation of gluconic acid as a by-product 
of citric acid production, is susceptible to external pH val-
ues due to its extracellular localization. Hence, the forma-
tion of gluconic acid is inhibited by maintaining low pH 
value of the cultivation medium during citric acid produc-
tion (Kubicek and Karaffa 2006).
Lockwood and Reeves (1945) noted the inhibitory 
effect of itaconic acid on its biosynthesis. Kanamasa et al. 
(2008) proved that the transcription of cadA is not affected 
by itaconic acid, so there is no feedback inhibition at the 
transcription level of cadA. However, cis-aconitate decar-
boxylase was shown to be inhibited by  Zn2+,  Hg+,  Cu2+, 
p-chloromercuribenzoate and 5,5′-dithio-bis(2-nitrobenzo-
ate) (Dwiarti et al. 2002). As noted by Klement and Buchs 
(2013), the regulation of cis-aconitate decarboxylase is still 
not understood and remains to be elucidated.
Interestingly, the requirement for low extracellular pH 
as a prerequisite for itaconic acid production is not con-
served across the fungal kingdom. For instance, according 
to Klement et al. (2012), the fungus Ustilago maydis per-
forms biosynthesis of itaconic acid within the pH range of 
4.5–6.0. In addition, unlike A. terreus, it uses an alternative 
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biosynthetic pathway involving trans-aconitate as an inter-
mediate (Geiser et al. 2016).
The association of the biosynthesis of itaconic acid 
and lovastatin with different growth conditions must have 
provided a certain sort of evolutionary advantage for the 
producing organism itself. One may speculate that the 
niche-dependent different biosynthesis of these metabolites 
supported the proliferation of A. terreus strains in diverse 
habitats. Lowering the pH value of the surroundings with 
itaconic acid and inhibiting the growth of competing 
microbes with lovastatin can be both viewed as the estab-
lished survival strategies employed under different environ-
mental conditions and encoded in the genome of A. terreus 
in the course of evolution.
Agitation and aeration
The cellular machinery responsible for the biosynthesis 
of itaconic acid and lovastatin, as well as the growth of 
A. terreus itself, are heavily dependent on oxygen supply. 
Accordingly, applying well-designed agitation and aeration 
strategies is a key to achieve industrially relevant produc-
tivities and titers. Since the formation of fungal metabolites 
is significantly influenced by morphology, it is crucial to 
determine an optimal agitation speed and aeration rate that 
provide a balance between delivering sufficient amounts of 
oxygen to the cells and avoiding high levels of mechanical 
stress.
The studies on itaconic acid and lovastatin production 
clearly demonstrate that, in general, insufficient agitation 
leads to hindered product formation due to the shortages in 
oxygen supply. On the contrary, if the stirring speeds are 
too high, the negative impact associated with shear stress 
dominates over the potential advantages of high dissolved 
oxygen tensions and, as a consequence, the final prod-
uct titers are rather low. The examples of relevant studies 
addressing the issue of optimal agitation during itaconic 
acid and lovastatin production are provided below.
Park et  al. (1993) applied stirring speeds ranging from 
200 to 400  rpm in order to evaluate the influence of agi-
tation on itaconic acid production by A. terreus IFO6365. 
Throughout the experiment, the aeration rate, expressed in 
the units of vvm (ratio of air flow rate and the volume of the 
bioreactor), was fixed at 0.5  lair  l− 1  min− 1. It was observed 
that the stirring speed of 200 rpm was too low to provide 
sufficient oxygen for the efficient itaconic acid production 
and, as a consequence, the final titer was below 20 g  l− 1. 
It was reflected by the fact that at the agitation speed of 
200  rpm the dissolved oxygen concentration decreased 
to zero after 6  h of cultivation. At the stirring speed of 
400  rpm the final concentration of the target metabo-
lite reached 32.3  g  l− 1 and the microscopic examination 
revealed the damage of mycelia due to the mechanical 
stress. The highest titer of itaconic acid (49.4  g  l− 1) was 
achieved at the moderate stirring speed of 300 rpm. Under 
these conditions, the compromise between providing suf-
ficient agitation and avoiding excessive shear stress was 
achieved. In addition, the authors evaluated the effect of 
dissolved oxygen (DO) concentration on the production 
of itaconic acid. In these experiments stirring speed was 
fixed at 300  rpm and aeration rate was manipulated to 
reach the anticipated level of DO, namely 20, 40 and 60%. 
The final concentration of the product was equal to 48.5, 
45.2 and 52 g  l− 1, respectively. Since the achieved product 
titers were similar for all three examined levels of DO, it 
was clear that increasing the aeration rate above a certain 
level was unnecessary in the context of itaconic acid forma-
tion (Park et  al. 1993). In a different study, changing the 
stirring speed from 320 to 400 rpm at pH 2.8 allowed for 
the elevation of the final product titer in the cultures of A. 
terreus NRRL 1960 from 17.7 to 43.1  g  l− 1, respectively 
(Riscaldati et  al. 2000). However, further increase of the 
stirring speed to 480 rpm was a step backwards in terms of 
itaconic acid concentration, which was found to be equal to 
33.1 g  l− 1. The presented trade-off between sufficient agi-
tation and maintaining adequate morphological forms was 
analogous to the one demonstrated by Park et al. (1993).
Looking beyond the morphological aspects, Pfeifer et al. 
(1952) pointed out that operating at high agitation and high 
aeration rates may be problematic due to excessive foaming 
of the culture broth. Therefore, the agitation and aeration 
during itaconic acid production were recommended to be 
increased only up to a certain point. The authors used the 
strain A. terreus NRRL 1960 and conducted their experi-
ments at a pilot plant scale of 200 and 400 gallons (Pfeifer 
et al. 1952).
The recommendation of conducting the cultivation at 
the “sufficient, but not too high” agitation speed and aera-
tion rate, formulated towards itaconic acid production, 
applies equally well to lovastatin biosynthesis. Lai et  al. 
(2005) monitored lovastatin formation by A. terreus ATCC 
20542 at 225, 325 and 425 rpm. Not surprisingly, the high-
est titer of 0.305 g  l− 1 was observed at the moderate stir-
ring speed of 325 rpm. The authors performed the second 
series of experiments to examine the influence of dissolved 
oxygen control on lovastatin biosynthesis. The cultiva-
tion was conducted at the DO controlled at 10, 20, 30 and 
40%. It turned out that controlling the DO at 20% proved 
to be an optimal choice in this case, leading to the titer of 
0.458 g l− 1. In the runs with the DO maintained at 10% the 
oxygen supply turned out to be insufficient, whereas at 30 
and 40% the titers were low due to the impact of mechani-
cal stress (Lai et al. 2005). A comparable phenomenon was 
observed in the cultures of A. terreus 20541 by Novak et al. 
(1997). This time, however, the best-yielding process was 
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conducted at the controlled DO of 70%, while the DO val-
ues of 35 and 80% were found to be, respectively, too low 
and too high to allow for the efficient lovastatin production. 
Despite the discrepancies in the suggested optimal DO val-
ues, the results of Lai et al. (2005) and Novak et al. (1997) 
supported the same common principle that the level of DO 
control needs to be carefully adjusted to prevent the dam-
age of mycelia. The morphological issues of lovastatin and 
itaconic acid production are further discussed in the next 
section.
In a different study, Bizukojc and Ledakowicz (2008) 
observed that the increase of aeration rate negatively 
affects lovastatin production by A. terreus ATCC 20542 
by promoting the formation of (+)-geodin. This behav-
ior was later confirmed by Boruta and Bizukojc (2016), 
whose results indicated that the intensive aeration scheme 
induced the production of (+)-geodin and terrein at the cost 
of lovastatin, which was found to be present at the notice-
ably lower concentration compared with the less aerated 
cultures.
Fungal morphology
Morphology is one of the key process-related parameters of 
submerged fungal cultivations (Grimm et al. 2005; Kossen 
2000; Wucherpfennig et  al. 2010). Generally, the fungus 
cultivated in the agitated liquid medium may proliferate in 
the form of dispersed hyphae, clumps or pellets (Gao et al. 
2014). The morphological form of a cultivated microorgan-
ism depends on a wide range of factors, including medium 
composition, temperature, pH, oxygen supply and, impor-
tantly, mechanical stress exerted by agitation. There are no 
general rules regarding the mycelial forms recommended 
for the efficient biosynthesis of metabolites or enzymes. 
While for certain products the formation of pellets is a pre-
requisite for achieving high titers and productivities, the 
biosynthesis of some other molecules may be favored by 
the presence of dispersed hyphae (Papagianni 2004).
The detailed studies addressing the influence of mor-
phological forms on the production of itaconic acid were 
performed by Gyamerah (1995a) and Gao et  al. (2014). 
According to Gyamerah (1995a), itaconic acid forma-
tion by A. terreus NRRL 1960 was favored in the pres-
ence of small and frayed pellets with the diameter in the 
range 0.1–0.5 mm. In the second study involving the strain 
A. terreus FMME033, Gao et al. (2014) noted that clumps 
with the diameter of 0.4–0.5 mm were preferred over pel-
lets. Therefore, the conclusions of Gao et  al. (2014) were 
in agreement with the ones presented by Gyamerah (1995a) 
with respect to the size, but not the type, of the morpho-
logical form. A markedly different opinion was presented 
by Rychtera and Wase (1981), who suggested to avoid the 
formation of pellets during itaconic acid production.
In the case of lovastatin biosynthesis, the search for opti-
mal morphology have been undertaken by several research 
groups (Bizukojc and Ledakowicz 2010; Casas Lopez 
et  al. 2005; Gbewonyo et  al. 1992; Gupta et  al. 2007; Jia 
et  al. 2009; Rodriguez Porcel et  al. 2006a, b). Although 
it is generally agreed that pellets are the morphological 
form desired for lovastatin formation, there is a great vari-
ety with respect to the suggested optimal diameters of the 
pellets, which were proposed, for example, to be less than 
1.5  mm (Bizukojc and Ledakowicz 2010), 0.95  mm on 
average (Lai et  al. 2005) or within the range 1.8–2.0 mm 
(Gupta et al. 2007).
Due to the discrepancies regarding the recommended 
optimal morphologies, it is difficult to make comparisons 
between lovastatin and itaconic acid production in this 
particular aspect. Nevertheless, the biosynthesis of both 
metabolites can be induced by using similar methods of 
morphology engineering. The traditional strategies of con-
trolling the morphological forms, involving the adjustment 
of mechanical stress and the number of spores, have been 
attempted in both cases (Bizukojc and Ledakowicz 2010; 
Casas Lopez et  al. 2005; Gao et  al. 2014) and shown to 
influence the outcome of the process. The modern meth-
ods employed to engineer fungal morphology typically 
involve the addition of mineral microparticles, e.g. alumin-
ium oxide or talc (Krull et  al. 2013; Walisko et  al. 2012, 
2015). This approach is referred to as the microparticle-
enhanced cultivation (MPEC) and has been successfully 
employed for enhancing lovastatin production (Gonciarz 
et al. 2016; Gonciarz and Bizukojc 2014). Even though the 
MPEC-based experiments were not yet tested with regard 
to itaconic acid production, the study of Gyamerah (1995a) 
involved a somewhat comparable strategy. In this work, the 
medium was supplemented with  CaSO4 at the concentra-
tion beyond its solubility limit. The presence of insoluble 
 CaSO4 led to the formation of small and frayed pellets. As 
a result, the improved production of the target metabolite 
was observed (Gyamerah 1995a).
Use of glucose and lactose as carbon sources
It is generally accepted that the highest yields of itaconic 
acids are reached with glucose as the carbon source (Kle-
ment and Buchs 2013; Okabe et al. 2009). Glucose is rap-
idly metabolized via glycolysis and the resulting influx 
of carbon directly feeds the TCA cycle, which in turn is 
responsible for cis-aconitic and itaconic acid production. 
Thus, high yields of itaconic acid obtained in the presence 
of glucose as the carbon source can be to some extent asso-
ciated with the architecture of the underlying metabolic 
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pathways (Mondala 2015). In order to decrease the man-
ufacturing costs, other carbon sources, e.g. beet molas-
ses, corn starch and sago starch, were also considered as 
alternatives to pure glucose (Dwiarti et  al. 2007; Nubel 
and Ratajak 1962; Petruccioli et al. 1999; Reddy and Singh 
2002; Yahiro et al. 1997).
Lai et  al. (2007) demonstrated that lactose, a slowly 
degradable carbon source, is preferred over glucose if lov-
astatin is the target metabolite, whereas the opposite pref-
erence was observed for itaconic acid. As already men-
tioned in the introduction, it is the only published report 
on the simultaneous biosynthesis of these two metabolites 
by a single strain of A. terreus (Lai et al. 2007). The final 
steps of lovastatin biosynthetic pathways are more dis-
tant from the core growth-associated primary metabolic 
machinery of the cell, what may be associated with the 
less preferable utilization of rapidly degradable glucose in 
this case.
Glycerol is another example of a carbon source widely 
used in lovastatin production (Abd Rahim et  al. 2015; Jia 
et  al. 2009; Lai et  al. 2003; Manzoni et  al. 1998; Pecyna 
and Bizukojc 2011). It was previously shown that glycerol 
is utilized by A. terreus at a lower rate than fructose, but 
still not as slowly as lactose (Casas Lopez et al. 2003).
Use of ammonium salts as nitrogen sources
Ammonium salts, namely ammonium nitrate and ammo-
nium sulfate, were used as sources of nitrogen in a majority 
of experimental efforts focused on itaconic acid produc-
tion (inter alia: Gyamerah 1995a; Hevekerl et  al. 2014b; 
Karaffa et al. 2015; Kautola et al. 1991; Kuenz et al. 2012; 
Nelson et al. 1952; Park et al. 1993; Riscaldati et al. 2000). 
Nelson et  al. (1952) pointed out specifically that the con-
sumption of ammonium ions originating from ammonium 
sulfate releases sulfuric acid and facilitates pH control by 
acidification of the broth. On the other hand, the decrease 
of pH should be continuously monitored in order to pre-
vent growth inhibition due to the very high concentration 
of hydrogen ions.
In contrast to the common utilization of ammonium salts 
during itaconic acid production, their use is definitely not 
recommended if lovastatin is the target metabolite. Hajjaj 
et  al. (2001) observed very poor titers of this metabolite 
when ammonium salts were applied as nitrogen sources. 
This was in agreement with the observations of Lai et  al. 
(2003), who noted strong inhibition of lovastatin biosynthe-
sis in the presence of ammonium sulfate. The explanation 
of this behavior is that the assimilation of ammonium ions 
is associated with the release of acids what, consequently, 
lowers the pH of the broth. In other words, the pH is shifted 
away from the values favoring lovastatin production.
Outlook
The results of bioprocess-related studies clearly demon-
strate that the conditions favoring the formation of ita-
conic acid and lovastatin are not identical, especially with 
respect to extracellular pH and the substrate preference. 
It is possible that their biosynthesis is inversely regulated 
in response to certain environmental stimuli. However, 
these two metabolites are markedly different in terms of 
chemical structure, biosynthetic origin, regulation and 
maximal reported titers. Itaconic acid is related to pri-
mary metabolism, whereas lovastatin is a textbook exam-
ple of a secondary metabolite. Considering the metabolic 
and regulatory differences, the existence of common 
regulation for itaconic acid and lovastatin biosynthesis is 
rather unlikely despite the adjacency of the correspond-
ing gene clusters. The biochemical investigation of mul-
tiple strains capable of performing simultaneous produc-
tion of these two metabolites would surely provide novel 
insights in this regard. Still, the molecular regulatory 
mechanisms behind the biosynthesis of itaconic acid and 
lovastatin remain enigmatic and need to be addressed in 
future experiments. Considering the fact that the pH pref-
erence behind itaconic acid formation is different in A. 
terreus than in U. maydis, there is a chance these unique 
regulatory mechanisms were evolutionarily shaped in 
concert with the formation of lovastatin/itaconic acid bio-
synthetic genomic region.
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